FDA Authorizes Marketing of First Next-generation Sequencing Test for Detecting HIV-1 Drug Resistance Mutations
WASHINTON, D.C. — The U.S. Food and Drug Administration authorized marketing of a test to detect human immunodeficiency virus (HIV) Type-1 drug resistance mutations using next-generation sequencing (NGS) technology. The …
Read More